Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07568093

PARO-agitation-study

Postoperative agitation is a common and serious complication in visceral and transplant surgery, associated with prolonged hospital stays and an increased risk of self-harm. Therefore, it is important to find an approach to improve the management of postoperative agitation and to reduce its duration and severity. The medical device "PARO" is a robotic seal that enables patient-robot-interaction. Patients respond to the device through verbal communication and motor responses, as well as facial expressions and gestures. The seal detects human interaction through audiovisual recognition, tactile sensors, and the integration of artificial intelligence. The aim of the study is to observe the use of "PARO" in patients undergoing elective visceral surgery and to analyze the occurence of agitation.

A decrease in the incidence of postoperative agitation is to be expected in a cohort of patients undergoing visceral surgery who use PARO compared to a group of patients undergoing visceral surgery who do not use PARO.

To monitor the occurrence of postoperative agitation, a standardized screening will be conducted twice daily for three days using the Richmond Agitation-Sedation Scale (RASS). To assess postoperative pain, anxiety and delirium, the Numerical Pain Scale (NRS), the State-Trait-Anxiety-Inventory (STAI) and a delirium screening tool (3D-CAM/CAM-ICU) are used by a trained study team. The occurrence of other neuropsychiatric symptoms and postoperative surgical complications will also be assessed.

Additionally, the interaction between PARO and the patients is analyzed regarding movements, reactions to haptic and auditory stimuli, and the frequency of interaction. Our approach involves quantitatively monitoring these metrics to collect sensor data from the robot and video recordings of the patients to identify facial expression and posture patterns. The use and acceptance of the robot on clinical wards by various professional groups are evaluated. The focus is particularly on nursing staff, who have the most interactions with patients. The project is complemented by a hygiene study examining how successfully the hygiene protocol is integrated into clinical routines and what challenges the use of PARO poses in an intensive care unit. The aim is also to examine the workflow and time-related aspects of its usage. The study will be submitted as a clinical trial of the medical device within its intended use, without any additional invasive or burdensome procedures, in accordance with the provisions of Section 15 of the Medical Practitioners Act (MBO).

Recruiting

Interested in participating?

Request Info

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Patient inclusion criteria:

  • ≥18 years of age
  • Elective visceral surgery
  • german-speaking
  • Patient is capable of giving informed consent

Patient exclusion criteria:

  • Known dementia
  • Known immunodeficiency
  • Anacusia
  • Acute damage to the central nervous system
  • A preoperative systemic infection
  • Pre-existing severe immunosuppression or colonization with multidrug-resistant organisms (methicillin resistant Staphylococcus aureus (MRSA), quadruple multidrug-resistant Gram-negative pathogens (MRGN), Candida auris, vancomycin-resistant enterococci (VRE), and linezolid-resistant enterococci (LRE))
  • Postoperative systemic infection
  • Drug dependence
  • Known chronic pain syndrome

Treatment and study plan

PARO

Device

Robotic Seal "PARO"

Primary outcomes

  1. Agitation

    Time frame: 1.-3.postoperative days

    measured via Richmond-agitation-sedation-scale (RASS)

Secondary outcomes

  1. Postoperative anxiety

    Time frame: Postoperative days 1-3

    measured via State-Trait-Anxiety-Inventory (STAI)

  2. Postoperative pain

    Time frame: Postoperative days 1-3

    measured via Numeric-Rating-scale (NRS)

  3. Postoperative delirium

    Time frame: Postoperative days 1-3

    measured via 3D-CAM/CAM-ICU

Study contacts

Contact information is provided by the study sponsor or research team.

Hans Worthmann, PD Dr.

CONTACT

[email protected]

+495115322393

Johannes Teller, Dr.

CONTACT

[email protected]

+495115323580

Sponsors and collaborators

Lead sponsor

Hannover Medical School

Other

Registry information

Official study title

Postoperative Agitation, Anxiety and Pain With the Use of the Robotic Tool PARO - A Prospective Randomised Study

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
May 5, 2026
Registry last updated
May 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.